Blood Pressure and Metabolic Changes After 3-Month CPAP Therapy in a Very Elderly Obese with Severe Obstructive Sleep Apnea: A Case Report and Review of the Literature
- PMID: 28324596
- DOI: 10.1007/s40292-017-0190-7
Blood Pressure and Metabolic Changes After 3-Month CPAP Therapy in a Very Elderly Obese with Severe Obstructive Sleep Apnea: A Case Report and Review of the Literature
Abstract
Age is one of the main risk factor for the presence of obstructive sleep apnea (OSA). This syndrome is associated with hypertension, cardiovascular disease, cognitive impairment and metabolic abnormalities, such as type 2 diabetes. Continuous positive airway pressure (CPAP) represents the gold standard therapy, but its benefit is still to be determined in very elderly. We report the blood pressure and metabolic changes in a very elderly obese with severe OSA after 3-month CPAP therapy. We have evaluated a very elderly obese male affected by severe symptomatic OSA, poor controlled nocturnal hypertension and insulin resistance. After 3-month CPAP therapy, without any changes in drug therapy, we observed a normalization of circadian blood pressure (BP) pattern, an improved insulin sensitivity, together with a reduced resting energy expenditure, despite no significant change in weight. This case report shows the benefits of OSA treatment with CPAP, not only on BP profile, but also on metabolic parameters in a very elderly, a particular type of patient in which scientific evidence is still scant. Further studies are needed to better investigate the relationship between OSA, CPAP therapy and energy expenditure not only in adults but also in elderly patients.
Keywords: Continuous positive airway pressure; Hypertension; Metabolism; Obesity; Obstructive sleep apnea; Very elderly.
Similar articles
-
Acute effects of continuous positive airway pressure in patients with obstructive sleep apnea.Scand Cardiovasc J. 2020 Feb;54(1):26-31. doi: 10.1080/14017431.2019.1659395. Epub 2019 Sep 3. Scand Cardiovasc J. 2020. PMID: 31476878
-
Obstructive Sleep Apnea Dynamically Increases Nocturnal Plasma Free Fatty Acids, Glucose, and Cortisol During Sleep.J Clin Endocrinol Metab. 2017 Sep 1;102(9):3172-3181. doi: 10.1210/jc.2017-00619. J Clin Endocrinol Metab. 2017. PMID: 28595341 Free PMC article. Clinical Trial.
-
Effects of continuous positive airway pressure treatment on clinic and ambulatory blood pressures in patients with obstructive sleep apnea and resistant hypertension: a randomized controlled trial.Hypertension. 2015 Apr;65(4):736-42. doi: 10.1161/HYPERTENSIONAHA.114.04852. Epub 2015 Jan 19. Hypertension. 2015. PMID: 25601933 Clinical Trial.
-
Is There a Role for Continuous Positive Airway Pressure Treatment in the Management of Obstructive Sleep Apnea-related Hypertension?Curr Hypertens Rev. 2017;13(2):89-92. doi: 10.2174/1573402113666170612094750. Curr Hypertens Rev. 2017. PMID: 28606037 Review.
-
Obstructive Sleep Apnea, Hypertension, and Cardiovascular Risk: Epidemiology, Pathophysiology, and Management.Curr Cardiol Rep. 2020 Jan 18;22(2):6. doi: 10.1007/s11886-020-1257-y. Curr Cardiol Rep. 2020. PMID: 31955254 Review.
Cited by
-
Clinical and Research Solutions to Manage Obstructive Sleep Apnea: A Review.Sensors (Basel). 2021 Mar 4;21(5):1784. doi: 10.3390/s21051784. Sensors (Basel). 2021. PMID: 33806496 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical